These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 9589033

  • 1. Biomodulation of Fluorouracil in colorectal cancer.
    Ardalan B, Luis R, Jaime M, Franceschi D.
    Cancer Invest; 1998; 16(4):237-51. PubMed ID: 9589033
    [Abstract] [Full Text] [Related]

  • 2. Preclinical and clinical aspects of biomodulation of 5-fluorouracil.
    Sotos GA, Grogan L, Allegra CJ.
    Cancer Treat Rev; 1994 Jan; 20(1):11-49. PubMed ID: 7507404
    [Abstract] [Full Text] [Related]

  • 3. Chemotherapeutic strategies in metastatic colorectal cancer: an overview of current clinical trials.
    Köhne-Wömpner CH, Schmoll HJ, Harstrick A, Rustum YM.
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):105-25. PubMed ID: 1373004
    [Abstract] [Full Text] [Related]

  • 4. Biomodulation of 5-fluorouracil with antifolates.
    Bertino JR.
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-52-S18-56. PubMed ID: 9420021
    [Abstract] [Full Text] [Related]

  • 5. Where do we stand with 5-fluorouracil?
    Schmoll HJ, Büchele T, Grothey A, Dempke W.
    Semin Oncol; 1999 Dec; 26(6):589-605. PubMed ID: 10606252
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sequential biochemical modulation of fluorouracil with folinic acid, N-phosphonacetyl-L-aspartic acid, and interferon alfa-2a in advanced colorectal cancer.
    Royce ME, McGarry W, Bready B, Dakhil SR, Belt RJ, Goodwin JW, Gray R, Hoff PM, Winn R, Pazdur R.
    J Clin Oncol; 1999 Oct; 17(10):3276-82. PubMed ID: 10506630
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Trimetrexate: review and current clinical experience in advanced colorectal cancer.
    Blanke CD, Messenger M, Taplin SC.
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-57-S18-63. PubMed ID: 9420022
    [Abstract] [Full Text] [Related]

  • 14. Phase I study of phosphonacetyl-L-aspartate, 5-fluorouracil, and leucovorin in patients with advanced cancer.
    Hageboutros A, Rogatko A, Newman EM, McAleer C, Brennan J, LaCreta FP, Hudes GR, Ozols RF, O'Dwyer PJ.
    Cancer Chemother Pharmacol; 1995 Oct; 35(3):205-12. PubMed ID: 7805178
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The pharmacologic modulation of 5-fluorouracil with folinic acid, methotrexate, trimetrexate, and n-phosphonacetyl-l-aspartic acid (PALA). Mechanisms of the interactions and clinical data.
    Machover D.
    Bull Cancer; 1994 Dec; 81 Suppl 2():74s-77s. PubMed ID: 7727863
    [No Abstract] [Full Text] [Related]

  • 18. Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer.
    Hageboutros A, Hudes GR, Greene F, LaCreta FP, Brennan J, O'Dwyer PJ.
    Invest New Drugs; 1997 Dec; 15(2):139-45. PubMed ID: 9220293
    [Abstract] [Full Text] [Related]

  • 19. [Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?].
    Carnaghi C, Zucali P, Garassino I.
    Tumori; 2000 Dec; 86(5 Suppl 2):S19-25. PubMed ID: 11195298
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.